Radiographic TBS is a significant predictor of long-term outcomes in HCC patients post-MWA, with higher scores linked to lower survival rates. Laparoscopic MWA outperforms percutaneous MWA, likely due ...
Pathologic treatment effect and first recurrence behavior after curative liver surgery for HCC. Adjuvant immune checkpoint inhibitor therapy after curative-intent resection or ablation for high-risk ...
Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion: A Japanese nationwide survey. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting ...
The pre-RFA blood HCC signature developed in the present study, which considers the blood levels of DCP (≥40 mAU/mL) and the cfDNA mutation score generated from cfDNA mutations in TP53, CTNNB1 and the ...
SBRT showed improved LPFS over RFA in treating single recurrent small HCC, especially for tumors ≤2 cm. Both SBRT and RFA demonstrated similar PFS, OS, and safety profiles, with mild to moderate side ...
RFA and anti-PD-1 combination therapy suppresses abscopal HCC tumors and prevents recurrence in mice
Hepatocellular carcinoma (HCC), the most prevalent form of primary liver cancer, remains a leading cause of cancer-related mortality worldwide. Although radiofrequency ablation (RFA) is the first-line ...
Please provide your email address to receive an email when new articles are posted on . Transcatheter arterial chemoembolization alone and with microwave ablation yielded comparable overall survival ...
For patients with early multinodular hepatocellular carcinoma (HCC) who are ineligible for liver transplant, liver resection provides a survival advantage over percutaneous radiofrequency ablation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results